Eizen Joshua M sold ANTX
March 19, 2026 · Form 4 insider transaction
Eizen Joshua M sold 92,000 shares of AN2 Therapeutics, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
92,000
Price
N/A
Total value
N/A
InsiderEizen Joshua M
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeD: Disposition to the issuer
Transaction dateMarch 19, 2026
Filing dateMarch 23, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.; The shares subject to the option vest as follows: 25% of the shares shall vest on the anniversary of September 29, 2022, and the remainder of the shares shall vest ratably monthly over the subsequent 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.